BC
TEVA icon

Bayforest Capital’s Teva Pharmaceuticals TEVA Stock Holding History

Bayforest Capital’s Portfolio TEVA Stock Details TEVA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$32.2K Sell
951
-504
-35% -$16.8K 0.03% 728
2026
Q1 		$43.8K Buy
+1,455
New +$46.8K 0.05% 596
2025
Q2 		– Sell
-3,723
Closed -$57.2K – 909
2025
Q1 		$57.2K Sell
3,723
-3,875
-51% -$69.2K 0.02% 549
2024
Q4 		$167K Buy
+7,598
New +$138K 0.21% 169

Other funds holding TEVA

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
HIIFS
Harel Insurance Investments & Financial Services Ramat Gan, Israel $20.6B AUM 59.59% 1-Year Est. Return
PF
Phoenix Financial Givatayim, Israel $14.6B AUM 57.48% 1-Year Est. Return
WCM Investment Management
WCM Investment Management Laguna Beach, California $55.2B AUM 57.07% 1-Year Est. Return
CI
Clal Insurance Tel-Aviv, Israel $22.3B AUM 79.91% 1-Year Est. Return
MMH
Menora Mivtachim Holdings Ramat Gan, Israel $25.6B AUM 50.04% 1-Year Est. Return
MIFH
Migdal Insurance & Financial Holdings Petach Tikva, Israel $15.6B AUM 71.29% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $1T AUM
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
LIM
Lingotto Investment Management London, United Kingdom $4.67B AUM 70.24% 1-Year Est. Return

Bayforest Capital's TEVA Position: Q2 2026 in Review

Bayforest Capital reduced its Teva Pharmaceuticals (TEVA) stake by 35% in Q2 2026, selling an estimated $16.8K and leaving 951 shares worth $32.2K. The position accounts for 0.03% of the portfolio, ranked #728.

Bayforest Capital first reported a position in TEVA in Q4 2024 and has held it in 4 quarters since. The position peaked at $167K in Q4 2024. 673 funds tracked by Wall St. Rank hold TEVA as of Q2 2026.

  • Bayforest Capital held 951 shares of Teva Pharmaceuticals worth $32.2K as of Q2 2026.
  • Bayforest Capital sold 504 Teva Pharmaceuticals shares in Q2 2026, an estimated $16.8K.
  • Teva Pharmaceuticals made up 0.03% of Bayforest Capital's portfolio in Q2 2026, its #728 holding.
  • Bayforest Capital first reported a position in Teva Pharmaceuticals in Q4 2024 and has held it in 4 quarters since.
  • Bayforest Capital's Teva Pharmaceuticals position peaked at $167K in Q4 2024.
  • 673 funds tracked by Wall St. Rank held Teva Pharmaceuticals as of Q2 2026.

Based on Bayforest Capital's 13F filing for Q2 2026, filed 5 Aug 2026.